Resultats globals: 2 registres trobats en 0.01 segons.
Articles, 2 registres trobats
Articles 2 registres trobats  
1.
10 p, 971.5 KB Comparison of High Doses of Total Body Irradiation in Myeloablative Conditioning before Hematopoietic Cell Transplantation / Sabloff, Mitchell (University of Ottawa and Ottawa Hospital Research Institute) ; Chhabra, Saurabh (Medical College of Wisconsin) ; Wang, Tao (Medical College of Wisconsin) ; Fretham, Caitrin (National Marrow Donor Program/Be the Match) ; Kekre, Natasha (The Ottawa Hospital Blood and Marrow Transplant Program and the Ottawa Hospital Research Institute) ; Abraham, Allistair (Children's National Medical Center) ; Adekola, Kehinde (Northwestern University) ; Auletta, Jeffery J. (Nationwide Children's Hospital) ; Barker, Christopher (Memorial Sloan Kettering Cancer Center) ; Beitinjaneh, Amer (University of Miami) ; Bredeson, Christopher (The Ottawa Hospital Blood and Marrow Transplant Program and the Ottawa Hospital Research Institute) ; Cahn, Jean-Yves (CHU Grenoble Alpes) ; Diaz, Miguel Angel (Hospital Infantil Universitario Niño Jesus) ; Freytes, Cesar (Texas Transplant Institute) ; Gale, Robert Peter (Imperial College London) ; Ganguly, Siddhartha (University of Kansas Health System) ; Gergis, Usama (New York Presbyterian Hospital/Weill Cornell Medical Center) ; Guinan, Eva (Dana-Farber Cancer Institute (Boston, Estats Units d'Amèrica)) ; Hamilton, Betty K. (Cleveland Clinic Taussig Cancer Institute) ; Hashmi, Shahrukh (King Faisal Specialist Hospital and Research Centre (Aràbia Saudita)) ; Hematti, Peiman (University of Wisconsin) ; Hildebrandt, Gerhard (University of Kentucky) ; Holmberg, Leona (Fred Hutchinson Cancer Research Center) ; Hong, Sanghee (Cleveland Clinic Taussig Cancer Center) ; Lazarus, Hillard M. (Case Western Reserve University) ; Martino Bofarull, Rodrigo (Institut d'Investigació Biomèdica Sant Pau) ; Muffly, Lori (Stanford University) ; Nishihori, Taiga (H. Lee Moffitt Cancer Center and Research Institute) ; Perales, Miguel-Angel (Memorial Sloan Kettering Cancer Center) ; Yared, Jean (University of Maryland) ; Mineishi, Shin (Penn State Hershey Medical Center) ; Stadtmauer, Edward A. (University of Pennsylvania Medical Center) ; Pasquini, Marcelo (Medical College of Wisconsin) ; Loren, Alison W. (Perelman School of Medicine at the University of Pennsylvania) ; Universitat Autònoma de Barcelona
Malignancy relapse is the most common cause of treatment failure among recipients of hematopoietic cell transplantation (HCT). Conditioning dose intensity can reduce disease relapse but is offset by toxicities. [...]
2019 - 10.1016/j.bbmt.2019.08.012
Biology of blood and marrow transplantation, Vol. 25 Núm. 12 (december 2019) , p. 2398-2407  
2.
10 p, 523.7 KB Risk Factors for Graft-versus-Host Disease in Haploidentical Hematopoietic Cell Transplantation Using Post-Transplant Cyclophosphamide / Im, Annie (University of Pittsburgh/UPMC Hillman Cancer Center) ; Rashidi, Armin (University of Minnesota) ; Wang, Tao (Medical College of Wisconsin) ; Hemmer, Michael (Medical College of Wisconsin) ; MacMillan, Margaret L. (University of Minnesota) ; Pidala, Joseph (H. Lee Moffitt Cancer Center and Research Institute) ; Jagasia, Madan (Vanderbilt University Medical Center) ; Pavletic, Steven (National Cancer Institute of Bethesda) ; Majhail, Navneet S. (Cleveland Clinic Taussig Cancer Institute) ; Weisdorf, Daniel (University of Minnesota) ; Abdel-Azim, Hisham (University of Southern California Keck School of Medicine) ; Agrawal, Vaibhav (Indiana University School of Medicine) ; Al-Homsi, A.Samer (New York University Langone Medical Center) ; Aljurf, Mahmoud (King Faisal Specialist Hospital and Research Centre (Aràbia Saudita)) ; Askar, Medhat (Baylor University Medical Center) ; Auletta, Jeffery J (Nationwide Children's Hospital) ; Bashey, Asad (Blood and Marrow Transplant Program at Northside Hospital) ; Beitinjaneh, Amer (University of Miami) ; Bhatt, Vijaya Raj (University of Nebraska Medical Center) ; Byrne, Michael (Vanderbilt University Medical Center) ; Cahn, Jean-Yves (CHU Grenoble Alpes) ; Cairo, Mitchell S (New York Medical College) ; Castillo, Paul (UF Health Shands Children's Hospital) ; Cerny, Jan (University of Massachusetts Medical Center) ; Chhabra, Saurabh (Medical College of Wisconsin) ; Choe, Hannah (The Ohio State University Wexner Medical Center) ; Ciurea, Stefan (The University of Texas MD Anderson Cancer Center) ; Daly, Andrew (Tom Baker Cancer Center) ; Perez, Miguel Angel Diaz (Hospital Infantil Universitario Nino Jesus) ; Farhadfar, Nosha (University of Florida College of Medicine) ; Gadalla, Shahinaz M. (NIH-NCI Clinical Genetics Branch) ; Gale, Robert (Imperial College London) ; Ganguly, Siddhartha (University of Kansas Health System) ; Gergis, Usama (Thomas Jefferson University) ; Hanna, Rabi (Cleveland Clinic Foundation) ; Hematti, Peiman (University of Wisconsin) ; Herzig, Roger (University of Kentucky Chandler Medical Center) ; Hildebrandt, Gerhard C. (University of Kentucky) ; Lad, Deepesh P. (Postgraduate Institute of Medical Education and Research) ; Lee, Catherine (University of Utah) ; Lehmann, Leslie (Dana-Farber Cancer Institute/Boston Children's Hospital) ; Lekakis, Lazaros (University of Miami) ; Kamble, Rammurti T. (Baylor College of Medicine) ; Kharfan-Dabaja, Momamed A. (Mayo Clinic) ; Khandelwal, Pooja (University of Cincinnati) ; Martino Bofarull, Rodrigo (Institut d'Investigació Biomèdica Sant Pau) ; Murthy, Hemant S. (Mayo Clinic) ; Nishihori, Taiga (Moffitt Cancer Center) ; O'Brien, Tracey A. (Sydney Children's Hospital) ; Olsson, Richard F. (Uppsala University) ; Patel, Sagar S. (University of Utah) ; Perales, Miguel-Angel (Memorial Sloan Kettering Cancer Center) ; Prestidge, Tim (Starship Children's Hospital (Auckland, Nova Zelanda)) ; Qayed, Muna (Emory University School of Medicine) ; Romee, Rizwan (Dana-Farber Cancer Institute (Boston, Estats Units d'Amèrica)) ; Schoemans, Hélène (University Hospitals Leuven (Bèlgica)) ; Seo, Sachiko (Dokkyo Medical University) ; Sharma, Akshay (St. Jude Children's Research Hospital (Memphis, Estats Units d'Amèrica)) ; Solh, Melhem (Northside Hospital) ; Strair, Roger (Rutgers University) ; Teshima, Takanori (Hokkaido University Hospital) ; Urbano-Ispizua, Alvaro (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Van der Poel, Marjolein (Maastricht University Medical Center) ; Vij, Ravi (Washington University School of Medicine) ; Wagner, John L. (Thomas Jefferson University) ; William, Basem (The Ohio State University) ; Wirk, Baldeep (Penn State Cancer Institute) ; Yared, Jean A. (University of Maryland) ; Spellman, Steve R. (Medical College of Wisconsin) ; Arora, Mukta (University of Minnesota Medical Center) ; Hamilton, Betty K. (Cleveland Clinic Taussig Cancer Institute) ; Universitat Autònoma de Barcelona
Post-transplant cyclophosphamide (PTCy) has significantly increased the successful use of haploidentical donors with a relatively low incidence of graft-versus-host disease (GVHD). Given its increasing use, we sought to determine risk factors for GVHD after haploidentical hematopoietic cell transplantation (haplo-HCT) using PTCy. [...]
2020 - 10.1016/j.bbmt.2020.05.001
Biology of blood and marrow transplantation, Vol. 26 Núm. 8 (august 2020) , p. 1459-1468  

Vegeu també: autors amb noms similars
1 Auletta, Jeffery J.
Us interessa rebre alertes sobre nous resultats d'aquesta cerca?
Definiu una alerta personal via correu electrònic o subscribiu-vos al canal RSS.